Ribociclib in HR+/HER2-Advanced or Metastatic Breast Cancer Patients

Rascon, K; Flajc, G; De Angelis, C; Liu, XL; Trivedi, MV; Ekinci, E

Trivedi, MV (reprint author), Univ Houston, Coll Pharm, Dept Pharm Practice & Translat Res, 4849 Calhoun Rd, Houston, TX 77204 USA.

ANNALS OF PHARMACOTHERAPY, 2019; 53 (5): 501

Abstract

Objective: To review the chemistry, pharmacology, pharmacokinetics, safety, and efficacy of ribociclib (LEE011, Kisqali) in hormone receptor-positive/......

Full Text Link